Latest Insider Transactions at Avidity Biosciences, Inc. (RNA)
This section provides a real-time view of insider transactions for Avidity Biosciences, Inc. (RNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Avidity Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Avidity Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
3,323
-18.31%
|
$139,566
$42.12 P/Share
|
|
Nov 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,323
+15.47%
|
$3,323
$1.24 P/Share
|
|
Nov 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
25,000
-21.01%
|
$1,025,000
$41.14 P/Share
|
|
Nov 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.36%
|
$350,000
$14.22 P/Share
|
|
Nov 06
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
106,319
-25.41%
|
$4,784,355
$45.63 P/Share
|
|
Nov 06
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,057
+20.21%
|
$553,399
$7.7 P/Share
|
|
Oct 21
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$230,000
$46.63 P/Share
|
|
Oct 21
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Oct 16
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
25,000
-21.01%
|
$1,200,000
$48.52 P/Share
|
|
Oct 16
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.36%
|
$350,000
$14.22 P/Share
|
|
Oct 07
2024
|
Tamar Thompson Director |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$1,320,000
$44.98 P/Share
|
|
Oct 07
2024
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$810,000
$27.63 P/Share
|
|
Oct 01
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
62,500
-42.26%
|
$2,937,500
$47.62 P/Share
|
|
Oct 01
2024
|
W. Michael Flanagan CSTO |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+29.71%
|
$1,625,000
$26.75 P/Share
|
|
Sep 23
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
13,153
-16.01%
|
$578,732
$44.0 P/Share
|
|
Sep 23
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
32,880
-12.29%
|
$1,446,720
$44.0 P/Share
|
|
Sep 23
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
25,000
-13.75%
|
$1,075,000
$43.95 P/Share
|
|
Sep 23
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,510
-10.67%
|
$506,440
$44.0 P/Share
|
|
Sep 19
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+22.17%
|
-
|
|
Sep 19
2024
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+18.16%
|
-
|
|
Sep 19
2024
|
W. Michael Flanagan CSTO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+21.46%
|
-
|
|
Sep 19
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+17.95%
|
-
|
|
Sep 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$225,000
$45.73 P/Share
|
|
Sep 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Sep 11
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
111,394
-31.95%
|
$4,455,760
$40.4 P/Share
|
|
Sep 11
2024
|
W. Michael Flanagan CSTO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,500
+27.39%
|
$2,316,000
$24.61 P/Share
|
|
Sep 11
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
25,000
-30.42%
|
$1,000,000
$40.4 P/Share
|
|
Sep 11
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.33%
|
$350,000
$14.22 P/Share
|
|
Sep 06
2024
|
Arthur A Levin Director |
BUY
Bona fide gift
|
Indirect |
22,500
+50.0%
|
-
|
|
Sep 06
2024
|
Arthur A Levin Director |
SELL
Bona fide gift
|
Indirect |
22,500
-14.62%
|
-
|
|
Aug 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$225,000
$45.19 P/Share
|
|
Aug 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Aug 06
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-12.02%
|
$1,204,000
$43.35 P/Share
|
|
Aug 06
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+10.73%
|
$28,000
$1.24 P/Share
|
|
Aug 01
2024
|
John B Moriarty Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Jul 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$225,000
$45.01 P/Share
|
|
Jul 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Jul 09
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-12.02%
|
$1,092,000
$39.93 P/Share
|
|
Jul 09
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+10.73%
|
$28,000
$1.24 P/Share
|
|
Jun 20
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$185,000
$37.59 P/Share
|
|
Jun 20
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Jun 18
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
10,106
-16.6%
|
$394,134
$39.13 P/Share
|
|
Jun 18
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
32,074
-18.37%
|
$1,250,886
$39.13 P/Share
|
|
Jun 18
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,228
-16.25%
|
$437,892
$39.13 P/Share
|
|
Jun 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
9,864
-23.47%
|
$384,696
$39.13 P/Share
|
|
Jun 17
2024
|
W. Michael Flanagan CSTO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.96%
|
-
|
|
Jun 17
2024
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+24.86%
|
-
|
|
Jun 17
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+24.87%
|
-
|
|
Jun 17
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+33.86%
|
-
|
|
Jun 14
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
35,767
-24.19%
|
$1,430,680
$40.08 P/Share
|